“We are also advancing our strategy implementation. Our multiphysics, multiscale technology roadmap will be enhanced with the planned acquisition of Exa to become part of our SIMULIA portfolio. The ability to simulate the impact of highly dynamic fluid flows is critical for industries, for cities and for medicine. For CATIA, the acquisition of No Magic will expand our systems engineering capabilities which will be critical contributors to the realization of autonomous vehicles and to the creation of entirely new customer experiences.

“Finally, at our North American 3DEXPERIENCE Forum last week, we shared important advances in our Living Heart Program, where our goal is to help to drive the creation and use of simulated 3D personalized hearts in the treatment, diagnosis and prevention of heart diseases, as one illustration of our many investments in Life Sciences. The digital Living Heart is now available through the 3DEXPERIENCE platform on the cloud, offering the speed and flexibility of high-performance computing (HPC) enabling medical device companies of all sizes and life sciences companies to have immediate access to a complete, on-demand HPC environment to scale up virtual testing securely and collaboratively.”